Free Trial

Synthomer (LON:SYNT) Reaches New 52-Week Low - Time to Sell?

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc shares reached a new 52-week low, trading at GBX 58.20 ($0.78) as investors reacted to various analyst price adjustments.
  • Analysts have downgraded their price targets for Synthomer, with Berenberg Bank reducing its target from GBX 120 to GBX 80, indicating a consensus rating of "Hold."
  • Recent insider trading showed significant purchases, with Jonathan Silver acquiring 59,229 shares at GBX 65, suggesting potential confidence in the company's future performance.
  • MarketBeat previews top five stocks to own in November.

Synthomer plc (LON:SYNT - Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as GBX 58.20 ($0.79) and last traded at GBX 58.50 ($0.79), with a volume of 891674 shares changing hands. The stock had previously closed at GBX 59.60 ($0.81).

Analyst Ratings Changes

SYNT has been the subject of a number of recent research reports. Berenberg Bank decreased their price objective on Synthomer from GBX 120 to GBX 80 and set a "hold" rating for the company in a report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft lowered their price objective on Synthomer from GBX 140 to GBX 115 and set a "hold" rating for the company in a research report on Wednesday, July 30th. Finally, Jefferies Financial Group reissued a "hold" rating and issued a GBX 100 price objective on shares of Synthomer in a research report on Tuesday, August 5th. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of GBX 142.50.

Get Our Latest Stock Analysis on SYNT

Synthomer Stock Performance

The company has a 50-day moving average price of GBX 79.78 and a two-hundred day moving average price of GBX 97.40. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 78.27. The stock has a market capitalization of £96.61 million, a P/E ratio of -115.66, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79.

Synthomer (LON:SYNT - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported GBX (5.40) EPS for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. On average, equities analysts forecast that Synthomer plc will post 12.962963 earnings per share for the current year.

Insider Transactions at Synthomer

In other news, insider Janet E. Ashdown bought 19,920 shares of the firm's stock in a transaction that occurred on Thursday, July 3rd. The stock was acquired at an average cost of GBX 99 per share, with a total value of £19,720.80. Also, insider Uwe Halder bought 25,000 shares of the firm's stock in a transaction that occurred on Thursday, August 7th. The stock was purchased at an average cost of GBX 64 per share, with a total value of £16,000. Over the last quarter, insiders acquired 124,149 shares of company stock valued at $8,701,965. 4.99% of the stock is currently owned by corporate insiders.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

See Also

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.